[21] Biomimic “Gemini nanoimmunoregulators”orchestrated for boosted photoimmunotherapy by spatiotemporally modulating PD-L1 and tumor associated macrophages. Acta Pharmaceutica Sinica B. 2024, 14(3): 1345-1361.

[22] Cell membrane-based biomimetic technology for cancer phototherapy: mechanisms, recent advances and perspectives. Acta Biomaterialia. 2024, 174: 26-48.

[23] Activatable biomimetic raspberry-like nanoplatform enabled robust cascade therapy via spatiotemporal regulation of tumor immunogenicity and immunosuppression. Chemical Engineering Journal. 2024, 479: 147563.

[24] Multifunctional bismuth-based gold-crowned nanocomposites for synergistic/enhanced sonodynamic, NIR-II biowindow photoinduced, and chemotherapeutic cancer therapy. ACS Applied Materials and Interfaces. 2023, 15: 58041-58053.

[25] Hemolysin from Aeromonas hydrophila enhances thehost's serum enzyme activity and regulates transcriptional responses in the spleen of Cyprinus rubrofuscus. Ecotoxicology and Environmental Safety. 2023, 263: 115375.

[26] Endoplasmic reticulum-mitochondrial calcium transport contributes to soft extracellular matrix-triggered mitochondrial dynamics and mitophagy in breast carcinoma cells. Acta Biomaterialia. 2023, 169: 192-208.

[27] Biomimetic nano-immunoactivator via ionic metabolic modulation for strengthened NIR-II photothermal immunotherapy. Small. 2023, 19: 2304370.

[28] NIR/pH-triggered chemo-phototherapy by aptamer-functionalized DNA origami nanovehicle for tumor-targeted delivery. Journal of Nanobiotechnology. 2023, 21: 186.

[29] Enhanced ferroptosis therapy with a “nano-destructor” by disrupting intracellular redox and iron homeostasis. Nano Today. 2023, 51: 101896.

[30] Stimulus-detonated biomimetic “nanobomb” with controlled release of HSP90 inhibitor to disrupt mitochondrial function for synergistic gas and photothermal therapy. Advanced Healthcare Materials. 2023, 12: 2300945.

[31] A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors. Acta Biomaterialia. 2023, 164: 522-537.

[32] Myosin regulates intracellular force and guides collective cancer cell migration via the FAK-Rho/ROCK feedback loop. Genes and Diseases. 2023, DOI: 10.1016/j.gendis.2023.02.037.

[33] Bio-inspired oxidative stress amplifier for suppressing cancer metastasis and imaging-guided combination therapy. ACS Applied Materials and Interfaces. 2023, 15: 6572-6583.

[34] Homologous targeting cascade nanobioreactor for autophagy inhibition amplified tumor catalytic therapy. ACS Materials Letters. 2023, 5: 491-503.

[35] Mesoporous silica nanoparticles-based nanoplatforms: basic construction, current state and emerging applications in anticancer therapeutics. Advanced Healthcare Materials. 2023, 12: 2201884.

[36] Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis. Chemical Engineering Journal. 2023, 452: 139506.

[37] Caveolin-1 signaling-driven mitochondrial fission and cytoskeleton remodeling promotes breast cancer migration. International Journal of Biochemistry and Cell Biology. 2022, 152: 106307.

[38] Shear stress enhances anoikis resistance of cancer cells through ROS and NO suppressed degeneration of cavelin-1. Free Radical Biology and Medicine. 2022, 193: 95-107.

[39] Polydopamine-engineered theranostic nanoscouts enabling intracellular HSP90 mRNAs fluorescence detection for multimodal imaging-guided chemo-photothermal therapy. Advanced Healthcare Materials. 2022, 11: 2201615.

[40] Tumor homing-penetrating and nanoenzyme-augmented 2D phototheranostics against hypoxic solid tumors. Acta Biomaterialia. 2022, 150: 391-401.